Fosun Pharma Launches AI-Driven PharmAID Platform for Enhanced Drug Development

Feb 17, 2025
Fosun Pharma has introduced its self-developed PharmAID decision intelligence platform, integrating advanced AI technologies to boost drug R&D efficiency, announced in a press release.

Fosun Pharma has introduced its self-developed PharmAID decision intelligence platform, integrating advanced AI technologies to boost drug R&D efficiency, announced in a press release. The platform is designed to enhance decision-making accuracy and accelerate the transformation of R&D achievements.

The PharmAID platform incorporates global leading large model technologies and connects with Deepseek R1, aiming to improve drug commercial value-assisted decision-making capabilities. It enhances drug R&D efficiency by integrating various predictive and analytical tools, such as point prediction, conformational prediction, and toxicology optimization.

Additionally, the platform offers AI translation and medical writing features, significantly improving information retrieval and writing efficiency. Fosun Pharma's initiative marks a significant step in the AI transformation of the pharmaceutical industry, aiming to lead innovation and transformation with its first self-developed AI decision intelligence platform.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.